Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Mao

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Preventive Medicine|February 16, 2006
Obesity and leisure time physical activity among CanadiansYue Chen, Yang Mao
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localizationYang Mao-Draayer, Hillel Panitch
Journal of Neurology|January 12, 2013
Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitorsYang Mao-Draayer, Tiyonnoh Cash
Neural Regeneration Research|February 19, 2016
Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathwayQin Wang, Yang Mao-Draayer
American Journal of Public Health|August 29, 2002
Avoidable mortality in the United States and Canada, 1980-1996Douglas G Manuel, Yang Mao
Clinical Immunology (Orlando, Fla.)|March 14, 2017
The gut microbiome and microbial translocation in multiple sclerosisAli Mirza, Yang Mao-Draayer
Pediatric Case Reviews (Print)|July 17, 2003
Two teenagers with headachesYang Mao-Draayer, Peter Bingham
Sozial- Und Praventivmedizin|August 2, 2003
Overweight and obesity in adults and risk of renal cell carcinoma in CanadaJinfu Hu, Yang Mao, Kathy White, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patientsElizabeth A Mills, Yang Mao-Draayer
Journal of Women'S Health (2002)|September 30, 2009
Association between obesity and depression in CanadiansYue Chen, Ying Jiang, Yang Mao
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Preventive Medicine|February 16, 2006
Obesity and leisure time physical activity among CanadiansYue Chen, Yang Mao
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localizationYang Mao-Draayer, Hillel Panitch
Journal of Neurology|January 12, 2013
Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitorsYang Mao-Draayer, Tiyonnoh Cash
Neural Regeneration Research|February 19, 2016
Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathwayQin Wang, Yang Mao-Draayer
American Journal of Public Health|August 29, 2002
Avoidable mortality in the United States and Canada, 1980-1996Douglas G Manuel, Yang Mao
Clinical Immunology (Orlando, Fla.)|March 14, 2017
The gut microbiome and microbial translocation in multiple sclerosisAli Mirza, Yang Mao-Draayer
Pediatric Case Reviews (Print)|July 17, 2003
Two teenagers with headachesYang Mao-Draayer, Peter Bingham
Sozial- Und Praventivmedizin|August 2, 2003
Overweight and obesity in adults and risk of renal cell carcinoma in CanadaJinfu Hu, Yang Mao, Kathy White, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patientsElizabeth A Mills, Yang Mao-Draayer
Journal of Women'S Health (2002)|September 30, 2009
Association between obesity and depression in CanadiansYue Chen, Ying Jiang, Yang Mao
Pageof 29